{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:52:17Z","timestamp":1762876337140,"version":"3.41.2"},"reference-count":19,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,20]]},"DOI":"10.31744\/einstein_journal\/2021ao6177","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T15:32:46Z","timestamp":1634743966000},"source":"Crossref","is-referenced-by-count":3,"title":["Treatment of oral chronic graft-versus-host disease: a retrospective cohort study"],"prefix":"10.31744","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-8692","authenticated-orcid":false,"given":"Gabriela de Assis","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-7503","authenticated-orcid":false,"given":"Ta\u00edsa Domingues Boehmer","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4952-5126","authenticated-orcid":false,"given":"Camila Brand\u00e3o","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-3759","authenticated-orcid":false,"given":"Paulo S\u00e9rgio da Silva","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-7199","authenticated-orcid":false,"given":"Maria Claudia Rodrigues","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-8019","authenticated-orcid":false,"given":"H\u00e9liton Spindola","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"3","key":"key20211020111526_B1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","unstructured":"1. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21(3): 389-401.e1.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"key20211020111526_B2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000421-198502000-00053","article-title":"Oral manifestations of bone marrow transplantation","volume":"8","author":"Carl","year":"1985","unstructured":"2. Carl W, Higby DJ. Oral manifestations of bone marrow transplantation. Am J Clin Oncol. 1985;8(1):81-7.","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"key20211020111526_B3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","unstructured":"3. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2005;11(12):945-56.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"key20211020111526_B4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archderm.138.6.838","article-title":"Oral involvement in chronic graft-vs-host disease following allogenic bone marrow transplantation","volume":"138","author":"Demarosi","year":"2002","unstructured":"4. Demarosi F, Bez C, Sardella A, Lodi G, Carrassi A. Oral involvement in chronic graft-vs-host disease following allogenic bone marrow transplantation. Arch Dermatol. 2002;138(6):842-3.","journal-title":"Arch Dermatol"},{"issue":"7","key":"key20211020111526_B5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group report","volume":"21","author":"Carpenter","year":"2015","unstructured":"5. Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group report. Biol Blood Marrow Transplant. 2015;21(7):1167-87.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"key20211020111526_B6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1703711","article-title":"Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation","volume":"30","author":"Couriel","year":"2002","unstructured":"6. Couriel DR, Beguelin GZ, Giralt S, De Lima M, Hosing C, Kharfan-Dabaja MA, et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant. 2002;30(8):543-6. Review.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"key20211020111526_B7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbmt.2010.06.015","article-title":"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD","volume":"16","author":"Wolff","year":"2010","unstructured":"7. Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant. 2010;16(12):1611-28.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"key20211020111526_B8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cden.2007.10.004","article-title":"Oral graft-versus-host disease","volume":"52","author":"Schubert","year":"2008","unstructured":"8. Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am. 2008;52(1):79-109,viii-ix. Review.","journal-title":"Dent Clin North Am"},{"issue":"8","key":"key20211020111526_B9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.oraloncology.2004.02.003","article-title":"Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus","volume":"40","author":"Eckardt","year":"2004","unstructured":"9. Eckardt A, Starke O, Stadler M, Reuter C, Hertenstein B. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncol. 2004;40(8):811-4.","journal-title":"Oral Oncol"},{"issue":"8","key":"key20211020111526_B10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbmt.2014.04.009","article-title":"Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease","volume":"20","author":"Noce","year":"2014","unstructured":"10. Noce CW, Gomes A, Shcaira V, Corr\u00eaa ME, Moreira MC, Silva J\u00fanior A, et al. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(8):1163-8.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"key20211020111526_B11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/bmt.2009.301","article-title":"Combined topical dexamethasone\/tacrolimus therapy for management of oral chronic GVHD","volume":"45","author":"Mawardi","year":"2010","unstructured":"11. Mawardi H, Stevenson K, Gokani B, Soiffer R, Treister N. Combined topical dexamethasone\/tacrolimus therapy for management of oral chronic GVHD. Bone Marrow Transplant. 2010;45(6):1062-7.","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"key20211020111526_B12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bmt.1700928","article-title":"Major salivar gland dysfunction in patients with hematological malignancies receicing interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT)","volume":"20","author":"Nagler","year":"1997","unstructured":"12. Nagler A, Nagler R, Ackerstein A, Levi S, Marmary Y. Major salivar gland dysfunction in patients with hematological malignancies receicing interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT). Bone Marrow Transplantat. 1997;20(7):575-80.","journal-title":"Bone Marrow Transplantat"},{"issue":"7","key":"key20211020111526_B13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1368-8375(01)00133-6","article-title":"Salivary gland hypofunction in patients with advanced cancer","volume":"38","author":"Davies","year":"2002","unstructured":"13. Davies AN, Broadley K, Beighton D. Salivary gland hypofunction in patients with advanced cancer. Oral Oncol. 2002;38(7):680-5.","journal-title":"Oral Oncol"},{"issue":"4","key":"key20211020111526_B14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/odi.12028","article-title":"Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research","volume":"19","author":"Mays","year":"2013","unstructured":"14. Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19(4):327-46. Review.","journal-title":"Oral Dis"},{"issue":"16","key":"key20211020111526_B15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2146\/ajhp120567","article-title":"Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease","volume":"70","author":"Park","year":"2013","unstructured":"15. Park AR, La HO, Cho BS, Kim SJ, Lee BK, Rhie JY, et al. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease. Am J Health Syst Pharm. 2013;70(16):1383-91.","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"key20211020111526_B16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0781.2004.00102.x","article-title":"Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease","volume":"20","author":"Wolff","year":"2004","unstructured":"16. Wolff D, Anders V, Corio R, Horn T, Morison WL, Farmer E, et al. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease. Photodermatol Photoimmunol Photomed. 2004;20(4):184-90.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"9","key":"key20211020111526_B17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archderm.137.9.1202","article-title":"Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients","volume":"137","author":"Choi","year":"2001","unstructured":"17. Choi CJ, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermatol. 2001; 137(9):1202-6.","journal-title":"Arch Dermatol"},{"issue":"3","key":"key20211020111526_B18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2133.2006.07679.x","article-title":"Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease","volume":"156","author":"Fricain","year":"2007","unstructured":"18. Fricain JC, Sibaud V, Swetyenga N, Tabrizi R, Campana F, Ta\u00efeb A. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. Br J Dermatol. 2007;156(3):588-90.","journal-title":"Br J Dermatol"},{"issue":"10","key":"key20211020111526_B19","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbmt.2010.03.023","article-title":"Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation","volume":"16","author":"Imanguli","year":"2010","unstructured":"19. Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant. 2010;16(10):1362-9. Erratum in: Biol Blood Marrow Transplant. 2016;22(6):1147.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T15:33:33Z","timestamp":1634744013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/treatment-of-oral-chronic-graft-versus-host-disease-a-retrospective-cohort-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":19,"alternative-id":["10.31744\/einstein_journal\/2021AO6177"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2021ao6177","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"type":"print","value":"1679-4508"},{"type":"electronic","value":"2317-6385"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"eAO6177"}}